2-Bromo-3-fluoroaniline (CAS NO : 111721-75-6)

2-Bromo-3-fluorophenylamine (CAS 111721-75-6) serves as a specialized building block within the API intermediates market, particularly for the synthesis of complex fluorinated aromatics used in oncology and antibacterial research. As CDMOs increasingly focus on precision medicine, there is a distinct shift toward sourcing from a bulk chemical supplier that can guarantee high-purity fine chemicals (99% Pharma/API purity) to ensure high-yield downstream couplings and minimal side-product formation. 1-Fluoro-2-bromo-3-aminobenzene (CAS 111721-75-6) is a critical precursor in the development of next-generation agrochemicals and pharmaceutical scaffolds, including potential applications in the synthesis of multi-kinase inhibitors. Global sourcing shifts toward audited manufacturing sites emphasize the need for custom synthesis services that provide comprehensive regulatory compliance and analytical validation, ensuring that the intermediate (99% Pharma/API purity | 98% General Industry purity) meets the stringent requirements of regulated markets. 2-Bromo-3-fluoroaniline (CAS 111721-75-6) is increasingly utilized in modern pharmaceutical synthesis as a regiospecific starting material for 4-substituted indoles and other heterocyclic frameworks. To navigate the evolving landscape of the API intermediates market, manufacturers are prioritizing high-purity fine chemicals (99% Pharma/API purity) to streamline scale-up processes and satisfy the quality assurance protocols demanded by global pharmaceutical formulators and innovative drug developers. We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API. We offer a broad range of pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical support (HPLC/NMR/MS), 2-Bromo-3-fluoroaniline COA/TDS/SDS, region-specific regulatory support, reliable lead times, and worldwide supply chain capabilities.